Designed as a Proof of Concept trial based on considerable pre-clinical work, the study's primary goal is the remission of the condition. A successful Proof of Concept ulcerative proctitis trial would be a key step in advancing the Brilacidin franchise into OTHER INFLAMMATORY BOWEL DISEASES.